.ANALYSIS FEATURE.06 August 2024.
A large randomized measured trial along with cisgender ladies highlights the obstacles of adherence to a daily dental preexposure treatment regiment and illustrates that twice-yearly treatment of lenacapavir can easily preserve reliable HIV deterrence levels over 6 months.